UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected Persons

Clinical infectious diseases, 2005-10, Vol.41 (7), p.1045-1048

2005

Volltextzugriff (PDF)

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals

Vaccine, 2011-04, Vol.29 (19), p.3558-3563

2011

Volltextzugriff (PDF)

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220

Vaccine, 2010-08, Vol.28 (34), p.5597-5604

2010

Volltextzugriff (PDF)

Sex Differences in Nevirapine Rash

Clinical infectious diseases, 2001-01, Vol.32 (1), p.124-129

2001

Volltextzugriff (PDF)

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Clinical infectious diseases, 2000-11, Vol.31 (5), p.1216-1224

2000

Volltextzugriff (PDF)

Pulmonary Cryptococcosis in Patients Without HIV Infection

Chest, 1999-03, Vol.115 (3), p.734-740

1999

Volltextzugriff (PDF)

Reply to Monroe and Brown

Clinical infectious diseases, 2014-06, Vol.58 (11), p.1640-1641

2014

Volltextzugriff (PDF)

Eradication of AIDS-Related Disseminated Mycobacterium avium Complex Infection after 12 Months of Antimycobacterial Therapy Combined with Highly Active Antiretroviral Therapy

The Journal of infectious diseases, 1998-11, Vol.178 (5), p.1446-1449

1998

Volltextzugriff (PDF)

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

The New England journal of medicine, 2020-03, Vol.382 (13), p.1232-1243

2020

Volltextzugriff (PDF)

Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy

Clinical infectious diseases, 2004-05, Vol.38 (10), p.1485-1489

2004

Volltextzugriff (PDF)

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

The Journal of infectious diseases, 2014-08, Vol.210 (3), p.354-362

2014

Volltextzugriff (PDF)

Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2004-09, Vol.39 (5), p.609-629

2004

Volltextzugriff (PDF)

Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS

Journal of clinical microbiology, 2001-02, Vol.39 (2), p.804-807

2001

Volltextzugriff (PDF)

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.339-354

2008

Volltextzugriff (PDF)

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

The New England journal of medicine, 2008-07, Vol.359 (4), p.355-365

2008

Volltextzugriff (PDF)

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

The Lancet infectious diseases, 2013-07, Vol.13 (7), p.587-596

2013

Volltextzugriff (PDF)

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women

Clinical infectious diseases, 2014-07, Vol.59 (1), p.127-135

2014

Volltextzugriff (PDF)

Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral Therapy–Induced Increases in CD4 + Cell Count: A Randomized, Double-Blind, Placebo-Controlled Trial

Annals of internal medicine, 2000-10, Vol.133 (7), p.493

Currier, Judith S.

2000

Volltextzugriff (PDF)

Dyslipidemia in HIV patients

Cleveland Clinic journal of medicine, 2005-12, Vol.72 (12), p.1113-1120

2005

Volltextzugriff (PDF)

Cardiovascular complications in HIV management: past, present, and future

Journal of acquired immune deficiency syndromes (1999), 2009-01, Vol.50 (1), p.54-64

Aberg, Judith A

2009

Volltextzugriff (PDF)

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study

Journal of acquired immune deficiency syndromes (1999), 2010-04, Vol.53 (4), p.456-463

2010

Volltextzugriff (PDF)

Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City

Sexually transmitted infections, 2011-06, Vol.87 (4), p.344-348

2011

Volltextzugriff (PDF)

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Clinical infectious diseases, 2003-09, Vol.37 (5), p.613-627

2003

Volltextzugriff (PDF)

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

AIDS (London), 2010-07, Vol.24 (11), p.1781-1784

2010

Volltextzugriff (PDF)

1 – 25 von 1.141

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(949)
Mit Volltextzugriff
(971)

Publikationsform

4 weitere anzeigen...

Weniger anzeigen...

Sprache

3 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected Persons

Lower peripheral blood CD14+ monocyte frequency and higher CD34+ progenitor cell frequency are associated with HBV vaccine induced response in HIV infected individuals

Immune response to hepatitis B vaccine in HIV-infected subjects using granulocyte-macrophage colony-stimulating factor (GM-CSF) as a vaccine adjuvant: ACTG study 5220

Sex Differences in Nevirapine Rash

Preliminary Guidelines for the Evaluation and Management of Dyslipidemia in Adults Infected with Human Immunodeficiency Virus and Receiving Antiretroviral Therapy: Recommendations of the Adult AIDS Clinical Trial Group Cardiovascular Disease Focus Group

Pulmonary Cryptococcosis in Patients Without HIV Infection

Reply to Monroe and Brown

Eradication of AIDS-Related Disseminated Mycobacterium avium Complex Infection after 12 Months of Antimycobacterial Therapy Combined with Highly Active Antiretroviral Therapy

Fostemsavir in Adults with Multidrug-Resistant HIV-1 Infection

Safety of Discontinuation of Maintenance Therapy for Disseminated Histoplasmosis after Immunologic Response to Antiretroviral Therapy

Dolutegravir in Antiretroviral-Experienced Patients With Raltegravir- and/or Elvitegravir-Resistant HIV-1: 24-Week Results of the Phase III VIKING-3 Study

Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Invasive fungal sinusitis and meningitis due to Arthrographis kalrae in a patient with AIDS

Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

Subgroup and Resistance Analyses of Raltegravir for Resistant HIV-1 Infection

Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials

Immunogenicity and Safety of the Quadrivalent Human Papillomavirus Vaccine in HIV-1–Infected Women

Long-Term Efficacy and Safety of Raltegravir Combined with Optimized Background Therapy in Treatment-Experienced Patients with Drug-Resistant HIV Infection: Week 96 Results of the BENCHMRK 1 and 2 Phase III Trials

Discontinuation of Mycobacterium avium Complex Prophylaxis in Patients with Antiretroviral Therapy–Induced Increases in CD4 + Cell Count: A Randomized, Double-Blind, Placebo-Controlled Trial

Dyslipidemia in HIV patients

Cardiovascular complications in HIV management: past, present, and future

Long-term efficacy and safety of the HIV integrase inhibitor raltegravir in patients with limited treatment options in a Phase II study

Awareness of post-exposure HIV prophylaxis in high-risk men who have sex with men in New York City

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

Suchergebnisse filtern